Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081934 | SCV000113869 | benign | not specified | 2013-07-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003764768 | SCV000290437 | benign | Absence seizure; Myoclonic epilepsy, juvenile, susceptibility to, 1 | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000264256 | SCV000464162 | uncertain significance | Juvenile myoclonic epilepsy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000443244 | SCV000510729 | likely benign | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000081934 | SCV000512924 | benign | not specified | 2016-12-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV003915095 | SCV004731069 | benign | EFHC1-related condition | 2019-07-18 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |